JP2008517949A5 - - Google Patents

Download PDF

Info

Publication number
JP2008517949A5
JP2008517949A5 JP2007538185A JP2007538185A JP2008517949A5 JP 2008517949 A5 JP2008517949 A5 JP 2008517949A5 JP 2007538185 A JP2007538185 A JP 2007538185A JP 2007538185 A JP2007538185 A JP 2007538185A JP 2008517949 A5 JP2008517949 A5 JP 2008517949A5
Authority
JP
Japan
Prior art keywords
cancer
compound
amine
pharmaceutical composition
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007538185A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008517949A (ja
JP5336082B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/038523 external-priority patent/WO2006047575A2/en
Publication of JP2008517949A publication Critical patent/JP2008517949A/ja
Publication of JP2008517949A5 publication Critical patent/JP2008517949A5/ja
Application granted granted Critical
Publication of JP5336082B2 publication Critical patent/JP5336082B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007538185A 2004-10-25 2005-10-25 抗腫瘍剤としてのイソホスホルアミドマスタードの塩及びその類似物 Expired - Fee Related JP5336082B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US62208704P 2004-10-25 2004-10-25
US60/622,087 2004-10-25
US67270705P 2005-04-18 2005-04-18
US60/672,707 2005-04-18
PCT/US2005/038523 WO2006047575A2 (en) 2004-10-25 2005-10-25 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

Publications (3)

Publication Number Publication Date
JP2008517949A JP2008517949A (ja) 2008-05-29
JP2008517949A5 true JP2008517949A5 (cg-RX-API-DMAC7.html) 2008-12-18
JP5336082B2 JP5336082B2 (ja) 2013-11-06

Family

ID=35788704

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007538185A Expired - Fee Related JP5336082B2 (ja) 2004-10-25 2005-10-25 抗腫瘍剤としてのイソホスホルアミドマスタードの塩及びその類似物

Country Status (17)

Country Link
US (4) US8232262B2 (cg-RX-API-DMAC7.html)
EP (3) EP1805192B1 (cg-RX-API-DMAC7.html)
JP (1) JP5336082B2 (cg-RX-API-DMAC7.html)
KR (2) KR20130041384A (cg-RX-API-DMAC7.html)
CN (3) CN101087800B (cg-RX-API-DMAC7.html)
AU (1) AU2005299385B2 (cg-RX-API-DMAC7.html)
CA (1) CA2585125C (cg-RX-API-DMAC7.html)
DK (2) DK2336140T3 (cg-RX-API-DMAC7.html)
ES (2) ES2565929T3 (cg-RX-API-DMAC7.html)
HK (1) HK1209752A1 (cg-RX-API-DMAC7.html)
IL (3) IL182752A (cg-RX-API-DMAC7.html)
NO (1) NO20072478L (cg-RX-API-DMAC7.html)
NZ (2) NZ589418A (cg-RX-API-DMAC7.html)
PL (1) PL1805192T3 (cg-RX-API-DMAC7.html)
PT (1) PT1805192E (cg-RX-API-DMAC7.html)
SI (1) SI1805192T1 (cg-RX-API-DMAC7.html)
WO (1) WO2006047575A2 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2585125C (en) 2004-10-25 2014-04-22 Lee Morgan Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
US7964583B2 (en) 2006-02-17 2011-06-21 Ziopharm Oncology, Inc. Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
KR20150139620A (ko) * 2007-04-06 2015-12-11 지오팜 온콜로지 인코포레이티드 이소포스포르아미드 머스타드의 염 및 이의 동족체
SG183657A1 (en) * 2008-07-31 2012-09-27 Ziopharm Oncology Inc Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof
WO2010099213A1 (en) 2009-02-24 2010-09-02 Dekk-Tec, Inc. Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents
CN102659841B (zh) * 2012-04-24 2015-03-25 石家庄学院 多元酚磷酰胺衍生物及其制备方法与应用
US10172789B2 (en) 2013-01-24 2019-01-08 Palvella Therapeutics Llc Compositions for transdermal delivery of mTOR inhibitors
CN108348780A (zh) * 2015-09-10 2018-07-31 贝克顿·迪金森公司 用作用于环磷酰胺和异环磷酰胺的免疫分析的免疫原和分析缀合物的环磷酰胺类似物
WO2018129364A1 (en) 2017-01-06 2018-07-12 Palvella Therapeutics Llc Anhydrous compositions of mtor inhibitors and methods of use
EP3684944B1 (en) 2017-09-21 2025-01-01 Becton, Dickinson and Company Hazardous contaminant collection kit and rapid testing
CN111107939B (zh) 2017-09-21 2022-04-12 贝克顿·迪金森公司 引导有害污染物样品的收集的系统和模板及使用其的方法
USD859683S1 (en) 2017-09-21 2019-09-10 Becton, Dickinson And Company Collection device
JP7223749B2 (ja) 2017-09-21 2023-02-16 ベクトン・ディキンソン・アンド・カンパニー 危険汚染物質の試験における高ダイナミックレンジの分析器
EP3817743A4 (en) 2018-07-02 2022-07-06 Palvella Therapeutics, Inc. ANHYDROUS COMPOSITIONS OF MTOR INHIBITORS AND METHODS OF USE
WO2020068657A1 (en) * 2018-09-25 2020-04-02 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 2'-halogenated-4'-thio-2'-deoxy-5-azacytidine analogs and use thereof
CN113383222A (zh) 2019-01-28 2021-09-10 贝克顿·迪金森公司 具有集成的拭子和测试装置的有害污染物收集装置
CN111973583A (zh) * 2020-07-29 2020-11-24 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 芹菜素在制备促进缺血超长随意皮瓣存活药物的作用
CN111943979B (zh) 2020-10-19 2020-12-22 南京卓康医药科技有限公司 一种异环磷酰胺中间体及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU427945A1 (ru) 1972-07-24 1974-05-15 Институт элементоорганических соединений СПОСОБ ПОЛУЧЕНИЯа ПОЛИФТОРАЛКИЛЗАМЕЩЕННЫХБЕНЗИЛДИХЛОРФОСФАТОВ
JPS5159886A (cg-RX-API-DMAC7.html) 1974-11-20 1976-05-25 Shionogi Seiyaku Kk
ZA851062B (en) * 1984-03-01 1985-11-27 Asta Werke Ag Chem Fab Salts of oxazaphosphorine derivatives and process for their production
PL264222A1 (en) * 1986-02-22 1988-04-14 Method of obtaining novel heterocyclic compounds with 2-(2-/n,n-bis-(2-chloroethyl)-diamido-phosphoryloxy/ethyl)group
US4841085A (en) * 1986-06-30 1989-06-20 Board Of Regents, University Of Texas System Aldophosphamides
US5055459A (en) * 1986-06-30 1991-10-08 Board Of Regents, The University Of Texas Selective elimination of malignant cells from bone marrow by bis (acyloxy) propylphosphoramidates
WO1993021173A1 (en) 1992-04-17 1993-10-28 Abbott Laboratories Taxol derivatives
US5468499A (en) * 1993-11-15 1995-11-21 Ohio State University Liposomes containing the salt of phosphoramide mustard and related compounds
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
JP4629238B2 (ja) * 1999-05-24 2011-02-09 サザン・リサーチ・インスティテュート イソホスホアミドマスタード・アナログ及びその使用
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
AU2001248201B2 (en) 2000-04-13 2006-12-14 Hsc Research And Development Limited Partnership Compounds for modulating cell proliferation
DE10064312C2 (de) * 2000-12-22 2003-05-22 Degussa Cholinpyruvat-Hydrat, Verfahren zu dessen Herstellung, Cholinpyruvat-Hydrat enthaltende Formulierung sowie deren Verwendung
ATE350383T1 (de) 2002-08-23 2007-01-15 Sloan Kettering Inst Cancer Synthese von epothilonen, zwischenprodukte dafür, analoga und deren verwendungen
CA2585125C (en) * 2004-10-25 2014-04-22 Lee Morgan Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
KR20150139620A (ko) 2007-04-06 2015-12-11 지오팜 온콜로지 인코포레이티드 이소포스포르아미드 머스타드의 염 및 이의 동족체
SG183657A1 (en) * 2008-07-31 2012-09-27 Ziopharm Oncology Inc Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof

Similar Documents

Publication Publication Date Title
RU2495045C2 (ru) Комплексное соединение самонамагничивающегося металла с саленом
JP2023551355A5 (cg-RX-API-DMAC7.html)
AU2019203966A1 (en) Functionalized polymers
HK1209752A1 (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
CA2653941A1 (en) Substituted amino purine derivatives and uses thereof
UA125655C2 (uk) Терапевтичні дендримери
ES2833459T3 (es) Compuestos que inhiben la ARN polimerasa, composiciones que incluyen dichos compuestos y su uso
ES3035949T3 (en) Sesquiterpene derivatives as well as pharmaceutical compositions thereof, preparation method therefor, and use thereof
CN103547564A (zh) 自磁性金属salen络合物化合物
JP2008303216A (ja) 抗腫瘍活性を有するポリメチレン誘導体をリガンドとする新規ビス−プラチナ複合体
CN106572991A (zh) 用于克服铂耐受性的德克萨卟啉‑pt(iv)缀合物及组合物
JP2924179B2 (ja) グリセロール誘導体,デバイス及び医薬組成物
RU2009140904A (ru) Соли изофосфорамидного иприта и его аналогов
JP2010523571A5 (cg-RX-API-DMAC7.html)
CN106565772A (zh) 一种新型双氨基的磷酰胆碱化合物Lys‑EG‑PC及其制备方法
TW201004631A (en) Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof
ES2910659T3 (es) Nuevo derivado de PEG
ES2743702T3 (es) Derivados hidroxibisfosfónicos hidrosolubles de la doxorrubicina
JP2012518659A5 (cg-RX-API-DMAC7.html)
CN104987296B (zh) 具有快速皮肤穿透速度的带正电荷的水溶性的芥子类化合物及其相关化合物的前药
CN108473676B (zh) 亚砜衍生物配位铂(ii)络合物的高分子偶联物
ITMI990811A1 (it) Composti dimerici di rutenio utili quali agenti antimetastatici ed antineoplastici
AU2011221388B2 (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
HK1185884A (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
IL159993A (en) Platinum complexes and pharmaceutical compositions comprising the same